Genital stimulation opens door for cryptic female choice in tsetse flies
May 14, 2009 |
not rated yet |
0
Manipulation of male and/or female genitalia results in a suite of changes in female reproductive behavior in tsetse flies, carriers of African sleeping sickness.
New study urges new thinking over UK government widening participation policy
May 14, 2009 |
not rated yet |
0
Widening participation efforts in UK universities should do more than simply create a 'wow moment' for young people, according to a new study led by the University of Leicester.
Study finds virtual doctors visits satisfactory for both patients and clinicians
May 14, 2009 |
not rated yet |
0
Travelers book plane tickets online, bank customers can check their accounts at any computer, and busy families can grocery shop online. Someday, even doctor visits could be among the conveniences offered via the Internet. ...
Ex-Rocky staffers plan to launch online magazine
May 14, 2009 |
not rated yet |
0
(AP) -- Some former staffers of the now-defunct Rocky Mountain News say they plan to launch an online news magazine this summer.
Motorola inks $310 mln deal with China Mobile
May 14, 2009 |
not rated yet |
0
Motorola announced on Thursday it has agreed to provide China Mobile Communications Corp. (CMCC) with 310 million dollars worth of mobile telecommunications equipment and services.
Gene hunters target child kidney failure
May 14, 2009 |
not rated yet |
0
Researchers are zeroing in on the genetic abnormalities predisposing to vesicoureteric reflux (VUR), one of the most common causes of urinary tract infections and kidney failure in children, reports a study in an upcoming ...
Test may help predict colon cancer recurrence risk
May 14, 2009 |
not rated yet |
0
A new gene test may help predict which colon cancer patients are at higher or lower risk of having their cancer return after surgery, doctors report, but whether it is useful enough to justify its likely high price remains ...
Immunotherapy effective against neuroblastoma in children
May 14, 2009 |
not rated yet |
0
A phase III study has shown that adding an antibody-based therapy that harnesses the body's immune system resulted in a 20 percent increase in the number of children living disease-free for at least two years with neuroblastoma. ...
